Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for LV Diastolic Function in ADPKD
NCT02119013Phase 3Completed
- Sponsor
- University of Naples Federico II
- Start
- Jan 2009
- Primary completion
- Sep 2013
- Modality
- Peptides
01
Overview
A Phase 3 trial of octreotide in autosomal dominant polycystic kidney disease (ADPKD), sponsored by University of Naples Federico II. Started Jan 2009; status: completed.
02
Drugs
octreotide
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT02119013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02119013.